Skip to main content

Technologies

14 results found
Diagnostics & Drug Delivery Pharmaceuticals / Nutraceuticals
Technologies
ID: 2018-037 This technology is based on the use of phages infecting a bacteria and, as a byproduct of phage infection, antimicrobial components are released that can kill nearby infectious pathogens
Technologies
ID: 2018-057 and 2014-098 BYU has discovered monocytes in the blood that provide a direct correlation to dopamine levels in the brain.
Technologies
ID: 2019-015 Recombinant human Gal-1 treatment improves membrane repair capacity, increases myogenic markers and decreases inflammation in dysferlin deficient myotubes, providing novel evidence regarding how Gal-1 favorably improves muscle function in LGMD2B.
Technologies
ID: 2019-016 A rapid, portable, and economic alternative to existing measurement methods for the activity or quantity of enzymes, enzyme inhibitors, or transcription- and translation-dependent biomolecules.
Technologies
ID: 2021-010 Using the power of Junctional Adhesion Molecules combined with the target of CAR-T to inhibit cancer metastasis and eradicate tumors.